With the exception of small amounts in elastin, all the hydroxyproline (OHPr) in the body is found in collagen. Evidence has been presented that the urinary peptide-bound OHPr reflects the metabolism of collagen (2-5) except when the dietary intake of gelatin or collagen is excessive. Since a major body depot of collagen is the matrix of bone, it might be anticipated that under some conditions the rate of OHPr excretion would furnish an index of the turnover of bone matrix.
With the exception of small amounts in elastin, all the hydroxyproline (OHPr) in the body is found in collagen. Evidence has been presented that the urinary peptide-bound OHPr reflects the metabolism of collagen (2) (3) (4) (5) except when the dietary intake of gelatin or collagen is excessive. Since a major body depot of collagen is the matrix of bone, it might be anticipated that under some conditions the rate of OHPr excretion would furnish an index of the turnover of bone matrix.
Parathyroid hormone is known to increase bone resorption (6) (7) (8) (9) (10) (11) . Thus, changes in parathyroid function might be expected to be associated with changes in OHPr excretion. Recently, Klein and Curtiss (12) reported that urinary OHPr first decreased and then increased in rats given parathyroid extract (PTE). Bates, McGowen, and Talmage noted that PTE increased plasma peptide-bound OHPr in rats (13) . An elevated urinary excretion of OHPr has been reported in patients with hyperparathyroidism (14) (15) (16) 3) Prolonged calcium infusions. Calcium glucoheptonate was given by continued iv infusion to three patients with hypoparathyroidism for 4 consecutive days while they were on a balance regimen similar to that used in the first group of experiments. The dosage of calcium averaged 7.5, 12.5, and 22.0 mg per kg per day in the three subjects, respectively. The 8 days before and after the infusion served as control periods. Blood was analyzed daily for Ca and P, and urine was collected daily for the determination of P, OHPr, and creatinine.
Chemical assays. Samples of diets, urine, and feces were analyzed for P by the method of Fiske and SubbaRow (17) , for total nitrogen by the method of Kjeldahl (18) , and for Ca by flame photometry; samples of urine were analyzed for creatinine (19) . Total OHPr was determined in hydrolyzed samples of urine and homogenized feces by the method of Prockop and Udenfriend (20 
Results
Effects of PTE. The effect of PTE in a normal subject is shown in Figure 1 and Table I . Serum Ca rose from 9.6 to 12.6 mg per 100 ml, and serum P fell from 3.4 to 1.9 mg per 100 ml. The changes in urinary OHPr, P, and Ca with PTE are summarized in Figure 3 and Table I . In all four subjects, urinary OHPr rose on the first day of PTE and remained elevated throughout the treatment period. The urinary Ca fell when PTE was first given, rose again to control levels within 1 to 4 days, and then rose still higher and remained elevated until PTE was stopped, whereupon it declined slowly towards control levels.
Effects of 4-hour calcium infusions. The rapid decrease in urinary OHPr when treatment with PTE was stopped suggested that significant changes in urinary OHPr might also be observed when endogenous secretion of parathyroid hormone was suppressed by infusion of calcium (24) . A typical response of a normal subject to calcium infusion is shown in detail in Figure 4 . Urinary OHPr decreased in the 4-hour period immediately following the infusion and remained low for the next 12 hours. A return towards normal levels was evident within 24 hours after the infusion. These changes were not closely correlated in time with the changes in urinary P. They occurred without apparent change in plasma OHPr and in the presence of a rising clearance of creatinine (CCr) . Pertinent data in nine normal subjects are summarized in Table II . The percentages of changes in the excretion of OHPr and of P from the control day in six of the subjects are plotted for the day of the infusion and the day following infusion in Figure 5 . On the day of infusion OHPr excretion decreased by 23 to 43%o (mean change, 37%o). On the day after infusion urinary OHPr was higher than on the day of infusion in five of the six subjects, but was still less than control values by 6 to 46%. On the day of infusion, phosphorus excretion decreased by 11 to 48% (mean change, 34%). On the day after infusion, urinary P varied from 72 to 146% of control values. Thus, all six normal subjects showed the classical decrease in urinary P excretion on the day of infusion, but only three had the previously reported rebound in P excretion on the following day (25) . Mean control OHPr was 38 mg per day with a range of 24 to 55 mg per day. Mean value on the day of infusion was 25 mg per day with a range of 17 to-32 mg per day.
Changes in OHPr excretion with calcium infusion do not appear to result from the calcium load per se, since a 4-hour infusion of Ca in two patients with hypoparathyroidism raised serum Ca and increased P excretion but did not significantly alter urinary OHPr ( Figure 6 and Table II) .
Effects of prolonged calcium infusions. A typical response of a patient with hypoparathyroidism to prolonged calcium infusion is shown in Figure  7 , and the results for three patients are shown in Table III gen metabolism, as indicated by urinary OHPr.
(Plasma OHPr did not show any apparent changes, but the sensitivity of the method is not great enough to preclude small changes paralleling the urinary ones.) All subjects who received PTE showed a prompt increase in urinary OHPr when treatment was begun and a rapid decrease when it was stopped. The converse was observed when calcium was infused in normal subjects.
Since the infusion of Ca did not decrease OHPr (or P) excretion in patients with hypoparathyroidism, we can reasonably conclude that the effect of calcium infusion on OHPr is an indirect one, depending on suppression of parathyroid activity. About 35 to 40%o of total body collagen is found in bone matrix (26) , which in turn constitutes about 30% of the dry weight of bone (27) . Osteoclasts may play a role in the process whereby Ca V. parathyroids induce breakdown of bone (28, 29) ; the increase in OHPr excretion presumably results from this breakdown of bone and of insoluble bone collagen. It is not clear, however, whether the collagen of organic matrix is altered directly, or after the salts have been removed. Bollet, Handy, and Parson (30) found that treatment of guinea pigs with PTE decreased the calcium content of bone without altering the collagen content; accordingly, they favor the latter alternative. In our own experiments, OHPr increased before urinary calcium (Figure 3 ), but this may merely reflect decreased renal clearance of calcium produced by PTE (31) . Similarly, the (35) found that PTE decreased the incorporation of C14-proline into collagen in vitro, there is no doubt that bone formation proceeds rapidly in the osteitis fibrosa cystica of hyperparathyroidism (36) . Preliminary reports (14) (15) (16) suggest that elevations of urinary OHPr occur in patients with hyperparathyroidism in whom alkaline phosphatase is elevated. In the present work, alkaline phosphatase did not rise with PTE. It was normal (8 King-Armstrong U) in a patient whom we have studied recently who had a parathyroid adenoma and normal bones by X-ray but whose urinary OHPr was significantly elevated (49 mg per 24 hours). Accordingly, if parathyroid hormone increases urinary OHPr by stimulating collagen synthesis, it can do so at doses that do not induce appreciable bone disease as estimated from the alkaline phosphatase. Klein (37) has recently reported that calcium infusion did not lower urinary OHPr in three patients with parathyroid adenomas. In our patient with a parthyroid adenoma, calcium infusion did not lower urinary OHPr.
It is clear that changes in parathyroid activity produce prompt parallel changes in urinary OHPr, presumably through effects on bone. Thus, urinary OHPr may provide a means of studying the effects of the parathyroids on the bones, independent of their effects on the renal tubules. Indeed, OHPr metabolism may prove to be useful for the study of bone metabolism in general.
Summary
In normal subjects and in patients with hypoparathyroidism, parathyroid extract produced prompt increases in the urinary excretion of hydroxyproline (OHPr); prompt decreases were seen when treatment was stopped. The changes in urinary hydroxyproline preceded those of urinary calcium but not those of urinary phosphorus.
Infusion of calcium produced rapid decreases in urinary hydroxyproline in normal subjects but not in patients with hypoparathyroidism. The decreases appeared within 6 hours and on occasion preceded the decreases in urinary phosphorus. Urinary OHPr, but not urinary phosphorus, was generally below control levels on the day following infusion of calcium.
The metabolism of body collagen, probably that of bone in particular, changes rapidly as parathyroid activity is altered; further evaluation of urinary hydroxyproline as an index of bone metabolism is suggested.
